Briefly: Nothing like it out there. Clinical trial successes....

Briefly:

Nothing like it out there.

Clinical trial successes.

Disruptional tech.

Babies being born every day of every year in every country, ie, recurring income.

Major partners involved in numerous countries, Mayo paying us to use tech and taking a bigger slice. Hapvida in Brazil is massive by itself.

Approvals at highest level in numerous countries. FDA is a pretty hard nut to crack.

Personal issues like living remotely and a 2 hour drive to a clinic and how much easier it would have been if this tech was around when we were going through the process.

And I like just being a year or 3 ahead of the pack normally..

Have made numerous posts stating my thoughts in here, you know what price CSL and COH listed at and how they progressed through commercialisation and the expenses of a start up.

Management.

HMD ticks a lot of boxes for me, may not be for everyones investment styles, I thought I'd be waiting 2-3 years for decent returns, which suits me fine, but Covid has accelerated their progress and I think decent returns will start flowing by end of this year.

Just a quick opinion, good luck with the days trading.

TCG